← Eichor
Study identifier: NCT07015983 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Condition: Lupus Erythematosus, Systemic · Lupus Nephritis  ·  Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

PhasePhase 2
Planned participants89
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (96)

Local Institution - 0106Phoenix, Arizona, United StatesNot Yet Recruiting
Local Institution - 0038Los Angeles, California, United StatesNot Yet Recruiting
Local Institution - 0051Los Angeles, California, United StatesNot Yet Recruiting
Local Institution - 0093Newport Beach, California, United StatesNot Yet Recruiting
Lucile Packard Children's HospitalPalo Alto, California, United StatesRecruiting
University of Colorado Anschutz Medical CampusAurora, Colorado, United StatesRecruiting
Local Institution - 0105Denver, Colorado, United StatesNot Yet Recruiting
Mayo Clinic in FloridaJacksonville, Florida, United StatesRecruiting
University of Miami Hospital and Clinics, Sylvester Cancer CenterMiami, Florida, United StatesRecruiting
Local Institution - 0073Orlando, Florida, United StatesNot Yet Recruiting
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
USF HealthTampa, Florida, United StatesRecruiting

+ 84 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07015983